Terms: = Sarcomas AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
187 results:
1. Elucidating the Diagnostic Complexity of Round Cell Sarcoma with EWSR1-CREM Fusion: A Comprehensive Case Study.
Yen H; Chou JL; Li YF; Wang DS
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674190
[TBL] [Abstract] [Full Text] [Related]
2. Reclassification of a spindle cell sarcoma after identification of a tfg-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma.
Lim JJ; Chen EY; Schaub SK; Wagner MJ
Mol Genet Genomic Med; 2024 Apr; 12(4):e2423. PubMed ID: 38622850
[TBL] [Abstract] [Full Text] [Related]
3. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
4. CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with alk fusion detected by flow cytometry and immunohistochemistry.
Iwakoshi A; Kikui H; Nakashima R; Goto Y; Ichikawa D; Sasaki E; Sekimizu M; Hattori H; Maeda N
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23228. PubMed ID: 38380728
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
[TBL] [Abstract] [Full Text] [Related]
6. Successful Crizotinib-targeted Therapy of Pediatric Unresectable ERC1::alk Fusion Sarcoma.
Wood ML; Fanburg-Smith JC; Brian JM; White JC; Powell JL; Freiberg AS
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e184-e187. PubMed ID: 38099690
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical analysis of lung adenocarcinoma with epidermal growth factor receptor mutation transformed into sarcoma].
Zhu QQ; Du MZ; Wu WT; Guo LC; Huang JA; Shen D
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):24-30. PubMed ID: 38062690
[No Abstract] [Full Text] [Related]
8. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
9. treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study.
Schiza A; Fredriksson I; Sund M; Valachis A
Breast Cancer Res Treat; 2024 Jan; 203(2):235-243. PubMed ID: 37812362
[TBL] [Abstract] [Full Text] [Related]
10. Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Ascierto PA; Di Giacomo AM; Chiarion Sileni V; Queirolo P; Spagnolo F; De Galitiis F; Cognetti F; Mandalà M; Guidoboni M; Rinaldi G; Depenni R; Consoli F; Troiani T; Guida M; Marconcini R; Ferrucci PF; Strippoli S; Fava P; Merelli B; Simeone E; Di Guardo L; Giannarelli D; Maio M; Quaglino P; Del Vecchio M
Eur J Cancer; 2023 Sep; 191():113246. PubMed ID: 37549531
[TBL] [Abstract] [Full Text] [Related]
11. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy.
Nakano K
Jpn J Clin Oncol; 2023 Oct; 53(10):885-892. PubMed ID: 37394916
[TBL] [Abstract] [Full Text] [Related]
12. Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.
Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
[TBL] [Abstract] [Full Text] [Related]
13. Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments.
Chen S; Tang J; Liu F; Li W; Yan T; Shangguan D; Yang N; Liao D
Front Immunol; 2023; 14():1094764. PubMed ID: 36949948
[TBL] [Abstract] [Full Text] [Related]
14. Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
Brazier E; Maruri F; Wester CW; Musick B; Freeman A; Parcesepe A; Hossmann S; Christ B; Kimmel A; Humphrey J; Freeman E; Enane LA; Lancaster KE; Ballif M; Golub JE; Nash D; Duda SN;
PLoS One; 2023; 18(3):e0268167. PubMed ID: 36917598
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological Analysis and treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
16. KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study.
Frost MG; Jensen KJ; Gotfredsen DR; Sørensen AMS; Ankarfeldt MZ; Louie KS; Sroczynski N; Jakobsen E; Andersen JL; Jimenez-Solem E; Petersen TS
Lung Cancer; 2023 Apr; 178():172-182. PubMed ID: 36868178
[TBL] [Abstract] [Full Text] [Related]
17. Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, treatment With Progesterone Receptor Modulators.
Check JH; Poretta T; Check D; Srivastava M
Anticancer Res; 2023 Mar; 43(3):951-965. PubMed ID: 36854512
[TBL] [Abstract] [Full Text] [Related]
18. Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and alk: Report of Three New Cases in the Head and Neck Region and Literature Review.
Gallagher KPD; Roza ALOC; Tager EMJR; Mariz BALA; Soares CD; Rocha AC; Abrahão AC; Romañach MJ; Carlos R; Hunter KD; Lopes MA; Vargas PA; Santos-Silva AR
Head Neck Pathol; 2023 Jun; 17(2):546-561. PubMed ID: 36374445
[TBL] [Abstract] [Full Text] [Related]
19. Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction.
Wan YY; Miao CL; Liu SB; Zhang T; Luo CH
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1212-1215. PubMed ID: 36089724
[TBL] [Abstract] [Full Text] [Related]
20. [Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy].
Jiang L; Zhang J; Hu J; Qi H; Xu H
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):477-481. PubMed ID: 35899444
[TBL] [Abstract] [Full Text] [Related]
[Next]
